| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |